453 related articles for article (PubMed ID: 34738855)
21. Psychometric testing of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy.
Cheng HL; Lopez V; Lam SC; Leung AKT; Li YC; Wong KH; Au JSK; Sundar R; Chan A; De Ng TR; Suen LKP; Chan CW; Yorke J; Molassiotis A
Health Qual Life Outcomes; 2020 Jul; 18(1):246. PubMed ID: 32703223
[TBL] [Abstract][Full Text] [Related]
22. Monosialotetrahexosylganglioside in the treatment of chronic oxaliplatin-induced peripheral neurotoxicity: TJMUCH-GI-001, a randomised controlled trial.
Zhou L; Liu R; Huang D; Li H; Ning T; Zhang L; Ge S; Bai M; Wang X; Yang Y; Wang X; Chen X; Gao Z; Luo L; Yang Y; Wu X; Deng T; Ba Y
EClinicalMedicine; 2021 Nov; 41():101157. PubMed ID: 34765950
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of Duloxetine on electrodiagnostic findings of Paclitaxel-induced peripheral neuropathy, does it have a prophylactic effect? A randomized clinical trial.
Aghabozorgi R; Hesam M; Zahed G; Babaee M; Hashemi M; Rayegani SM
Anticancer Drugs; 2023 Jun; 34(5):680-685. PubMed ID: 36730548
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of the Motivational Interviewing-Walk Intervention for Chemotherapy-Induced Peripheral Neuropathy and Quality of Life During Oxaliplatin Treatment: A Pilot Randomized Controlled Trial.
Kanzawa-Lee GA; Ploutz-Snyder RJ; Larson JL; Krauss JC; Resnicow K; Lavoie Smith EM
Cancer Nurs; 2022 Mar-Apr 01; 45(2):E531-E544. PubMed ID: 34483279
[TBL] [Abstract][Full Text] [Related]
25. Comparative study of the effects of venlafaxine and duloxetine on chemotherapy-induced peripheral neuropathy.
Farshchian N; Alavi A; Heydarheydari S; Moradian N
Cancer Chemother Pharmacol; 2018 Nov; 82(5):787-793. PubMed ID: 30105459
[TBL] [Abstract][Full Text] [Related]
26. Acupuncture for Bortezomib-Induced Peripheral Neuropathy: Not Just for Pain.
Zhi WI; Ingram E; Li SQ; Chen P; Piulson L; Bao T
Integr Cancer Ther; 2018 Dec; 17(4):1079-1086. PubMed ID: 30027756
[TBL] [Abstract][Full Text] [Related]
27. Effect of duloxetine in Japanese patients with chemotherapy-induced peripheral neuropathy: a pilot randomized trial.
Hirayama Y; Ishitani K; Sato Y; Iyama S; Takada K; Murase K; Kuroda H; Nagamachi Y; Konuma Y; Fujimi A; Sagawa T; Ono K; Horiguchi H; Terui T; Koike K; Kusakabe T; Sato T; Takimoto R; Kobune M; Kato J
Int J Clin Oncol; 2015 Oct; 20(5):866-71. PubMed ID: 25762165
[TBL] [Abstract][Full Text] [Related]
28. Study protocol: fish oil supplement in prevention of oxaliplatin-induced peripheral neuropathy in adjuvant colorectal cancer patients - a randomized controlled trial. (OxaNeuro).
Gehr NL; Karlsson P; Timm S; Christensen S; Hvid CA; Peric J; Hansen TF; Lauritzen L; Finnerup NB; Ventzel L
BMC Cancer; 2024 Feb; 24(1):168. PubMed ID: 38308227
[TBL] [Abstract][Full Text] [Related]
29. Protective effect of N-acetylcysteine on oxaliplatin-induced neurotoxicity in patients with colorectal and gastric cancers: A randomized, double blind, placebo-controlled, clinical trial.
Bondad N; Boostani R; Barri A; Elyasi S; Allahyari A
J Oncol Pharm Pract; 2020 Oct; 26(7):1575-1582. PubMed ID: 32063109
[TBL] [Abstract][Full Text] [Related]
30. Prevention of oxaliplatin-related neurotoxicity by ω-3 PUFAs: A double-blind randomized study of patients receiving oxaliplatin combined with capecitabine for colon cancer.
Zhang X; Chen H; Lu Y; Xu C; Yao W; Xu L; Zhang R; Zhang L; Yao Q
Medicine (Baltimore); 2020 Dec; 99(50):e23564. PubMed ID: 33327312
[TBL] [Abstract][Full Text] [Related]
31. Role of metformin in oxaliplatin-induced peripheral neuropathy in patients with stage III colorectal cancer: randomized, controlled study.
El-Fatatry BM; Ibrahim OM; Hussien FZ; Mostafa TM
Int J Colorectal Dis; 2018 Dec; 33(12):1675-1683. PubMed ID: 29931409
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the effect of N-acetylcysteine on the prevention and amelioration of paclitaxel-induced peripheral neuropathy in breast cancer patients: a randomized controlled study.
Khalefa HG; Shawki MA; Aboelhassan R; El Wakeel LM
Breast Cancer Res Treat; 2020 Aug; 183(1):117-125. PubMed ID: 32601973
[TBL] [Abstract][Full Text] [Related]
33. Neuroendocrine Stress Axis-Dependence of Duloxetine Analgesia (Anti-Hyperalgesia) in Chemotherapy-Induced Peripheral Neuropathy.
Staurengo-Ferrari L; Bonet IJM; Araldi D; Green PG; Levine JD
J Neurosci; 2022 Jan; 42(3):405-415. PubMed ID: 34880120
[TBL] [Abstract][Full Text] [Related]
34. Preventive effect of Goshajinkigan on peripheral neurotoxicity of FOLFOX therapy (GENIUS trial): a placebo-controlled, double-blind, randomized phase III study.
Oki E; Emi Y; Kojima H; Higashijima J; Kato T; Miyake Y; Kon M; Ogata Y; Takahashi K; Ishida H; Saeki H; Sakaguchi Y; Yamanaka T; Kono T; Tomita N; Baba H; Shirabe K; Kakeji Y; Maehara Y
Int J Clin Oncol; 2015 Aug; 20(4):767-75. PubMed ID: 25627820
[TBL] [Abstract][Full Text] [Related]
35. Chemotherapy-induced peripheral neuropathy and impact on quality of life 6 months after treatment with chemotherapy.
Beijers A; Mols F; Dercksen W; Driessen C; Vreugdenhil G
J Community Support Oncol; 2014 Nov; 12(11):401-6. PubMed ID: 25856013
[TBL] [Abstract][Full Text] [Related]
36. Vitamin E for prevention of oxaliplatin-induced peripheral neuropathy: a pilot randomized clinical trial.
Afonseca SO; Cruz FM; Cubero Dde I; Lera AT; Schindler F; Okawara M; Souza LF; Rodrigues NP; Giglio Ad
Sao Paulo Med J; 2013; 131(1):35-8. PubMed ID: 23538593
[TBL] [Abstract][Full Text] [Related]
37. Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance).
Loprinzi CL; Qin R; Dakhil SR; Fehrenbacher L; Flynn KA; Atherton P; Seisler D; Qamar R; Lewis GC; Grothey A
J Clin Oncol; 2014 Apr; 32(10):997-1005. PubMed ID: 24297951
[TBL] [Abstract][Full Text] [Related]
38. Use of acupuncture with acupressure in addition to standard-of-care cryotherapy to decrease chemotherapy-associated neuropathy in patients with gastrointestinal malignancies receiving oxaliplatin-based chemotherapy: Study protocol for a randomized, controlled pilot and feasibility study.
Cohen SA; Veleber S; Siman J; Guthrie KA; McMillen K; Heit M; Wadhera S; Daniels J; Hansen K; Jacoby M; Taromina K; Chin S; Romeo M; Langley BO; Coveler AL; Hannan LM; King G; Purcell T; Safyan RA; Shankaran V; Zhen DB; Chiorean EG; Greenlee H
Contemp Clin Trials; 2023 Aug; 131():107273. PubMed ID: 37380021
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of metformin in prevention of paclitaxel-induced peripheral neuropathy in breast cancer patients: a randomized controlled trial.
Bakry HM; Mansour NO; ElKhodary TR; Soliman MM
Front Pharmacol; 2023; 14():1181312. PubMed ID: 37583905
[No Abstract] [Full Text] [Related]
40. Effectiveness of Duloxetine on Oxaliplatin-induced Allodynia and Hyperalgesia in Rats.
Wagner MA; Smith EML; Ayyash N; Toledo J; Rasheed Z; Holden JE
Biol Res Nurs; 2024 Apr; 26(2):248-256. PubMed ID: 37902612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
